Clinical trial
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in…
NCT00417989 · Medtronic Diabetes, Industry · Completed
Key facts
| NCT number | NCT00417989 |
|---|---|
| Title | Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy |
| Official title | The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy |
| Acronym | STAR3 |
| Lead sponsor | Medtronic Diabetes, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Device |
| Interventions | MiniMed Paradigm REAL-Time System |
| Enrollment | 485 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Jun 1, 2010 |
| First posted | Jan 4, 2007 |
| Last update posted | May 23, 2018 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: